Insight

María Natalia Gandur Quiroga: Mutations and DNA Structures Driving Bladder Cancer

María Natalia Gandur Quiroga/X

Oct 11, 2024, 19:37

María Natalia Gandur Quiroga: Mutations and DNA Structures Driving Bladder Cancer

María Natalia Gandur Quiroga recently shared a post on LinkedIn:

“Study Uncovers Mutations and DNA Structures Driving Bladder Cancer.

New mutations and DNA structures drive bladder cancer, according to a study from Weill Cornell Medicine and the New York Genome Center.
APOBEC3 antiviral enzymes mutate DNA, triggering early-stage bladder cancer.
Cisplatin chemotherapy causes bursts of mutations, helping cancer cells resist treatment.
Extrachromosomal circular DNA (ecDNA) promotes therapy resistance in bladder cancer.
This study highlights new therapeutic strategies for a hard-to-treat cancer.”

APOBEC3 bladder cancer cancer Cisplatin DNA Structures María Natalia Gandur Quiroga mutations New York Genome Center OncoDaily Oncology Weill Cornell Medicine

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer